Does Dr. MOUSTAPHA ABIDALI have financial conflicts of interest?

Dr. MOUSTAPHA ABIDALI (DO) has received a total of $2,708 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,708 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MOUSTAPHA ABIDALI?

According to CMS Open Payments data, Dr. MOUSTAPHA ABIDALI received funding from GLAXOSMITHKLINE ($735), ASTRAZENECA PHARMACEUTICALS ($525), and REGENERON HEALTHCARE SOLUTIONS ($478).

Does Dr. MOUSTAPHA ABIDALI receive research grants or speaking fees?

Dr. MOUSTAPHA ABIDALI has received $2,708 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MOUSTAPHA ABIDALI

DOReal-Time Hydrated

Specialty: Internal Medicine, Pulmonary Disease

Practice Location: GLENDORA, CA 91741

NPI Number: 1669810123

LIFETIME INDUSTRY VALUE

$2,708

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABIDALI is a verified Internal Medicine, Pulmonary Disease practitioner based in GLENDORA, CA.

Between 2021 and 2025, Dr. ABIDALI had an overall industry promotional and research financial footprint of $2,708 as recorded in the federal CMS Open Payments database.

$2,708 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABIDALI's primary funding source is GLAXOSMITHKLINE, which accounts for $735 (representing 27.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAXOSMITHKLINE

Rank 1

$735

27.1%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$525

19.4%

REGENERON HEALTHCARE SOLUTIONS

Rank 3

$478

17.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.